Dietary exposure and health risk assessment of fumonisins through the consumption of maize and maize-based gluten-free products in individuals with celiac disease | Synapse
March 3, 2026Open Access
Dietary exposure and health risk assessment of fumonisins through the consumption of maize and maize-based gluten-free products in individuals with celiac disease
Key Points
Health risks of fumonisins in maize highlight the need for regular monitoring.
Continuous dietary guidance protects vulnerable populations from exposure.
Assessment of maize products finds potential health risks for individuals with celiac disease.
Stricter regulatory oversight is essential to ensure food safety for affected individuals.
Abstract
These findings highlight the need for continuous monitoring and stricter regulatory oversight and dietary guidance to protect vulnerable populations.